HomeCompareDPHAY vs EPRT

DPHAY vs EPRT: Dividend Comparison 2026

DPHAY yields 0.32% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DPHAY wins by $176.4K in total portfolio value· pulled ahead in Year 8
10 years
DPHAY
DPHAY
● Live price
0.32%
Share price
$98.00
Annual div
$0.31
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$239.8K
Annual income
$149,585.30
Full DPHAY calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — DPHAY vs EPRT

📍 DPHAY pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDPHAYEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DPHAY + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DPHAY pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DPHAY
Annual income on $10K today (after 15% tax)
$27.08/yr
After 10yr DRIP, annual income (after tax)
$127,147.50/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, DPHAY beats the other by $116,232.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DPHAY + EPRT for your $10,000?

DPHAY: 50%EPRT: 50%
100% EPRT50/50100% DPHAY
Portfolio after 10yr
$151.6K
Annual income
$81,213.01/yr
Blended yield
53.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

DPHAY
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DPHAY buys
0
EPRT buys
0
No recent congressional trades found for DPHAY or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDPHAYEPRT
Forward yield0.32%3.92%
Annual dividend / share$0.31$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%29%
Portfolio after 10y$239.8K$63.4K
Annual income after 10y$149,585.30$12,840.73
Total dividends collected$212.5K$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DPHAY vs EPRT ($10,000, DRIP)

YearDPHAY PortfolioDPHAY Income/yrEPRT PortfolioEPRT Income/yrGap
1$10,764$63.71$11,205$505.18$441.00EPRT
2$11,645$128.17$12,672$682.46$1.0KEPRT
3$12,720$259.20$14,490$930.48$1.8KEPRT
4$14,139$529.19$16,786$1,282.69$2.6KEPRT
5$16,229$1,099.53$19,753$1,791.56$3.5KEPRT
6$19,723$2,358.88$23,677$2,541.64$4.0KEPRT
7$26,463$5,358.65$29,008$3,672.99$2.5KEPRT
8← crossover$41,754$13,438.58$36,463$5,425.08+$5.3KDPHAY
9$84,310$39,633.28$47,238$8,221.57+$37.1KDPHAY
10$239,797$149,585.30$63,385$12,840.73+$176.4KDPHAY

DPHAY vs EPRT: Complete Analysis 2026

DPHAYStock

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Full DPHAY Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this DPHAY vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DPHAY vs SCHDDPHAY vs JEPIDPHAY vs ODPHAY vs KODPHAY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.